What to Expect When Paying for Mistletoe Injections in India

 Mistletoe therapy, derived from the Viscum album plant, has been widely used in Europe as a complementary treatment in cancer care. With the growing demand for integrative oncology in India, ABNOBA India, the regional partner of Germany-based ABNOBA GmbH, now offers mistletoe injections under medical supervision.

But what does this therapy cost?

The price of mistletoe injections can vary depending on several key factors. These include the type of ABNOBA product prescribed, the dosage strength, and the patient’s treatment protocol. ABNOBA produces a range of standardized mistletoe extracts, each tailored to different tumor types and treatment stages, from early cancer support to advanced cases.

In India, a single ampoule of mistletoe injection typically costs between ₹1,500 to ₹3,500, depending on the series and concentration. However, this is only part of the picture. A full course may involve two to three injections per week, potentially resulting in a monthly cost of ₹12,000 to ₹30,000 or more.

Additional costs may include consultation with integrative oncologists, administration charges, and routine monitoring, especially in hospital settings. Some insurance providers may partially cover it under supportive care, but coverage is not guaranteed.

While mistletoe is not a cure, many cancer patients use it to enhance well-being, reduce chemotherapy side effects, and support immune response.

Patients are advised to seek treatment through authorized medical professionals to ensure quality and safety.





Comments

Post a Comment

Popular posts from this blog

Exploring the Healing Potential of Mistletoe Therapy in Cancer Care

Image
 Mistletoe therapy, long integrated into European oncology practices, is gaining global recognition for its ability to enhance the overall well-being of cancer patients. Manufactured by ABNOBA GmbH , a leading German research-based pharmaceutical company, mistletoe extracts are now accessible in India through ABNOBA India , bringing a powerful complementary approach to supportive cancer care. Unlike conventional treatments that directly target tumors, mistletoe therapy works by stimulating the body’s own defenses . Its active ingredients, including mistletoe lectins , help activate immune cells and regulate the immune response—crucial during cancer treatment, when immunity is often compromised. One of mistletoe therapy’s most appreciated benefits is its impact on quality of life . Clinical studies have shown that patients receiving mistletoe extracts often report reduced treatment-related fatigue , nausea , and emotional distress , leading to better energy levels and a more stabl...
Read more

Unlocking the Healing Potential of Mistletoe Extracts in Modern Medicine

Image
Mistletoe ( Viscum album ) is more than just a symbol of tradition—it holds immense therapeutic promise in the field of integrative oncology. For decades, mistletoe extracts have been utilized in Europe, particularly in German-speaking countries, as a supportive treatment for cancer patients. Their role in enhancing immune function, improving tolerance to chemotherapy, and increasing overall well-being is well documented through scientific and clinical research. ABNOBA GmbH , a reputable German pharmaceutical company based in Pforzheim, is a pioneer in the development and production of standardized mistletoe extracts. With a commitment to scientific rigor and patient safety, ABNOBA ensures that its products maintain high levels of purity, consistency, and efficacy. Through ABNOBA India, these advanced therapies are now accessible to a wider patient base in South Asia, bridging the gap between traditional European therapies and modern Indian medical practices. The therapeutic compoun...
Read more

Scientific Evidence Supporting Mistletoe Therapy in Oncology

Image
Mistletoe therapy, derived from the European mistletoe plant ( Viscum album ), has gained attention as a complementary treatment in oncology, particularly in German-speaking countries. ABNOBA GmbH, a research-driven pharmaceutical company based in Pforzheim, Germany, has been at the forefront of developing standardized mistletoe extracts used in integrative cancer care. Scientific investigations over the past few decades have supported the potential benefits of mistletoe therapy in cancer treatment . Preclinical studies indicate that mistletoe extracts possess immunomodulatory, apoptotic (cell death-inducing), and cytotoxic effects against various tumor cell lines. These properties are largely attributed to mistletoe lectins and viscotoxins, key bioactive compounds in the extract. Clinical research, including randomized controlled trials, has shown that mistletoe therapy can improve quality of life, reduce chemotherapy side effects such as fatigue and nausea, and possibly extend surv...
Read more